DADenizhan Akpinar

Denizhan Akpinar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Denizhan Akpinar has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Posterior Chordae Rupture of the Tricuspid Valve due to Myocardial Infarction: A Rare Entity Among Tricuspid Valve Pathologies

    by Endri Balla, Arif Okay Karslıoğlu, Zoukou Marie France Dominique Seri, Denizhan Akpınar, Ecem Tuğba Yamaç, Elshad Mansımzada, Hakkı Tankut Akay, Elvin Kesimci, Atila Sezgin

    The tricuspid valve is rarely affected by myocardial infarction. The right ventricle has a lower systolic pressure compared to the left ventricle making the papillary muscles of the tricuspid valve more resistant to ischemia. The right coronary artery is the main blood supply to tricuspid papillary muscles, chordae rupture of the tricuspid valve may occur following myocardial infarction. Here, we present a rare case of a 70-year-old male with severe tricuspid regurgitation, a completely occluded right coronary artery (RCA), 70% stenosis of the left main coronary artery (LMCA), and 100% occlusion of the left anterior descending artery (LAD). The patient’s ejection fraction (EF) was reduced to 30%. Treatment included tricuspid valve repair using the bicuspidization technique and a five-vessel coronary artery bypass graft (CABG). This case demonstrates that, although rare, myocardial infarction can involve the tricuspid valve and that the surgery of the valve with full revascularization proved to be an effective treatment strategy in our patient.

  • Open Access

    Compari̇son of PTFE sutures with polypropylene sutures in suprapopliteal femoropopliteal bypass with PTFE grafts

    by Hakki Tankut Akay, Deniz Sarp Beyazpinar, Bahadır Gültekin, Arif Okay Karslioglu, Denizhan Akpinar, Endri Balla, Ecem Tugba Yamac, Elsad Mansımzade, Asuman Nihan Haberal Reyhan, Atila Sezgin

    Aim: Infrainguinal bypass surgery stands as the predominant open surgical procedure for lower limb revascularization and is reserved for cases of intermittent claudication (IC) that have proven unresponsive to maximal medical management. Polypropylene monofilament sutures have been widely used for peripheral vascular surgery operations. Aim of this study is comparing this new type of suture with propylene sutures.Material and Methods: Between January 2022 and December 2022, two cohorts who underwent suprapopliteal femoropopliteal bypass surgery, each comprising 15 patients were included in the study. In Group I (polytetrafluoroethylene (PTFE) Group), PTFE served as the suture material, whereas in Group 2 (Non PTFE Group), polypropylene sutures were employed. All preoperative demographics, perioperative and postoperative data were collected carefully. Results: All patients underwent surgical interventions due to either rest pain or ischemic ulcers. Among the 30 patients, 11 fell into Fontaine class 4, while 19 were categorized as Fontaine class 3. Out of the 30 patients, 18 received cilostazol treatment. The mean age of the patient cohort was 66.97±7.4 years, with a mean body mass index of 29.03±6.2. When we compared the two groups, no statistically significant difference was found between groups according to demographic data. In the evaluation of intraoperative data, the mean operation time was 88.7±9.37 minutes, and the mean hemostasis time was 5.8±2.8 minutes. Group I (PTFE group) exhibited significantly lower hemostasis time and drainage levels on the first and second postoperative days (p<0.0001, p=0.03, and p=0.017, respectively). The use of absorbable hemostats were significantly less in PTFE suture group. Conclusion: The selection of sutures significantly influences the achievement of soft tissue approximation, reduced inflammation, suture hole leakage and capsule formation.


  • A Left Ventricular Assist Device is the Best Treatment Method for Elderly Patients with Advanced Heart Failure

    by Deniz Sarp Beyazpinar, Mehmet Emir Erol, Denizhan Akpinar, Arif Okay Karslioğlu, Hakkı Tankut AKAY, Atilla Sezgin

    Introduction: In end stage heart failure, cardiac transplantation is the gold standart treatment. But advance age (>65 years old) is one of the relative contrindication for cardiac trasnplantation. So these patients were left to their faith out of medical treatment. Material and Methods: Between april 2012 to december 2023, 98 left ventricular assit device implantation patients were retrospectively analysed. Patients divided into two group according to their ages (>65; <65 years old). Group were compared according to preoperative, perioperative and postoperative parameters. Results: The demographic datas, preoperative cardiac parameters, perioperative datas, postoperative datas and complication were similar according to statistically analyses. Statistically, the only difference between the groups is the day on which device thrombosis developed. Conclusion: Although the number of patients on the heart transplant list increases day by day, the number of donors does not increase. For this reason, advanced age is considered a relative contraindication for heart transplantation in many clinics. For this reason, the elderly patient group is left helpless apart from medical treatment. This study showed that left ventricular assist device therapy is a good alternative to transplantation in the group of patients sentenced to medical treatment. Keywords: Heart-Assist Devices; Heart Transplantation; Heart Failure.